Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 978

1.

Association of Depression Risk with Patient Experience, Healthcare Expenditure, and Health Resource Utilization Among Adults with Atherosclerotic Cardiovascular Disease.

Okunrintemi V, Valero-Elizondo J, Michos ED, Salami JA, Ogunmoroti O, Osondu C, Tibuakuu M, Benson EM, Pawlik TM, Blaha MJ, Nasir K.

J Gen Intern Med. 2019 Sep 5. doi: 10.1007/s11606-019-05325-8. [Epub ahead of print]

PMID:
31489560
2.

Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis.

Li C, Wang MD, Lu L, Wu H, Yu JJ, Zhang WG, Pawlik TM, Zhang YM, Zhou YH, Gu WM, Wang H, Chen TH, Han J, Xing H, Li ZL, Lau WY, Wu MC, Shen F, Yang T.

Hepatol Int. 2019 Sep 5. doi: 10.1007/s12072-019-09981-0. [Epub ahead of print]

PMID:
31486964
3.

Patient Perceptions About the Role of Religion and Spirituality During Cancer Care.

Merath K, Palmer Kelly E, Hyer JM, Mehta R, Agne JL, Deans K, Fischer BA, Pawlik TM.

J Relig Health. 2019 Sep 3. doi: 10.1007/s10943-019-00907-6. [Epub ahead of print]

PMID:
31482443
4.

Response: Oncologic outcomes of minimally invasive vs open distal pancreatectomy for pancreatic neuroendocrine tumors: Randomized controlled trials are needed.

Zhang XF, Pawlik TM.

J Surg Oncol. 2019 Sep 2. doi: 10.1002/jso.25693. [Epub ahead of print] No abstract available.

PMID:
31476082
5.

Biliary Tract and Primary Liver Tumors.

Pawlik TM.

Surg Oncol Clin N Am. 2019 Oct;28(4):xiii-xiv. doi: 10.1016/j.soc.2019.07.002. Epub 2019 Jul 26. No abstract available.

PMID:
31472919
6.

Intrahepatic Cholangiocarcinoma.

El-Diwany R, Pawlik TM, Ejaz A.

Surg Oncol Clin N Am. 2019 Oct;28(4):587-599. doi: 10.1016/j.soc.2019.06.002. Review.

PMID:
31472907
7.

Therapeutic index of lymphadenectomy among patients with pancreatic neuroendocrine tumors: A multi-institutional analysis.

Wu L, Sahara K, Tsilimigras DI, Maithel SK, Poultsides GA, Rocha FG, Weber SM, Fields RC, Idrees K, Cho CS, Shen F, Pawlik TM; and other members of the U.S. Neuroendocrine Tumor Study Group.

J Surg Oncol. 2019 Aug 29. doi: 10.1002/jso.25689. [Epub ahead of print]

PMID:
31468550
8.

Clinical Utility of Autologous Salvaged Blood: a Review.

Frank SM, Sikorski RA, Konig G, Tsilimigras DI, Hartmann J, Popovsky MA, Pawlik TM, Waters JH.

J Gastrointest Surg. 2019 Aug 29. doi: 10.1007/s11605-019-04374-y. [Epub ahead of print]

PMID:
31468332
9.

Handheld projective imaging device for near-infrared fluorescence imaging and intraoperative guidance of sentinel lymph node resection.

Li C, Liu P, Shao P, Pei J, Li Y, Pawlik TM, Martin EW, Xu RX.

J Biomed Opt. 2019 Aug;24(8):1-4. doi: 10.1117/1.JBO.24.8.080503.

10.

Development and validation of a risk score to predict the overall survival following surgical resection of hepatocellular carcinoma in non-cirrhotic liver.

Dasari BV, Kamarajah SK, Hodson J, Pawlik TM, Vauthey JN, Ma YT, Punia P, Coldham C, Abradelo M, Roberts KJ, Marudanayagam R, Sutcliffe RP, Muiesan P, Mirza DF, Isaac J.

HPB (Oxford). 2019 Aug 12. pii: S1365-182X(19)30621-5. doi: 10.1016/j.hpb.2019.07.007. [Epub ahead of print]

PMID:
31416786
11.

Novel Machine Learning Approach to Identify Preoperative Risk Factors Associated With Super-Utilization of Medicare Expenditure Following Surgery.

Hyer JM, Ejaz A, Tsilimigras DI, Paredes AZ, Mehta R, Pawlik TM.

JAMA Surg. 2019 Aug 14. doi: 10.1001/jamasurg.2019.2979. [Epub ahead of print]

PMID:
31411664
12.

Discordance in prediction of prognosis among patients with intrahepatic cholangiocarcinoma: A preoperative vs postoperative perspective.

Moro A, Paredes AZ, Farooq A, Sahara K, Tsilimigras DI, Mehta R, Endo I, Guglielmi A, Aldrighetti L, Alexandrescu S, Marques HP, Shen F, Koerkamp BG, Sasaki K, Pawlik TM; other members of the International Intrahepatic Cholangiocarcinoma Study Group.

J Surg Oncol. 2019 Aug 13. doi: 10.1002/jso.25671. [Epub ahead of print]

PMID:
31410852
13.

Association between body mass index and postoperative morbidity after liver resection of hepatocellular carcinoma: A multicenter study of 1,324 patients.

Yu JJ, Liang L, Lu L, Li C, Xing H, Zhang WG, Mao XH, Zeng YY, Chen TH, Zhou YH, Wang H, Pawlik TM, Wu H, Lau WY, Wu MC, Shen F, Yang T.

HPB (Oxford). 2019 Aug 9. pii: S1365-182X(19)30615-X. doi: 10.1016/j.hpb.2019.06.021. [Epub ahead of print]

PMID:
31405776
14.

Factors associated with switching between low and super utilization in the surgical population: A study in medicare expenditure.

Hyer JM, Tsilimigras DI, Gani F, Sahara K, Ejaz A, White S, Pawlik TM.

Am J Surg. 2019 Aug 5. pii: S0002-9610(19)30765-2. doi: 10.1016/j.amjsurg.2019.07.042. [Epub ahead of print]

PMID:
31405521
15.

Analysis of Authorship in Hepatopancreaticobiliary Surgery: Women Remain Underrepresented.

Farooq A, Sahara K, Muneeb A, Farooq K, Tsilimigras DI, Merath K, Mehta R, Paredes A, Wu L, Hyer JM, Beal E, Pawlik TM, Dillhoff ME.

J Gastrointest Surg. 2019 Aug 8. doi: 10.1007/s11605-019-04340-8. [Epub ahead of print]

PMID:
31396842
16.

Trends in the Geospatial Distribution of Adult Inpatient Surgical Cancer Care Across the United States.

Diaz A, Schoenbrunner A, Pawlik TM.

J Gastrointest Surg. 2019 Aug 8. doi: 10.1007/s11605-019-04343-5. [Epub ahead of print]

PMID:
31396841
17.

Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma.

Akateh C, Black SM, Conteh L, Miller ED, Noonan A, Elliott E, Pawlik TM, Tsung A, Cloyd JM.

World J Gastroenterol. 2019 Jul 28;25(28):3704-3721. doi: 10.3748/wjg.v25.i28.3704. Review.

18.

The Prognostic Impact of Primary Tumor Site Differs According to the KRAS Mutational Status: A Study By the International Genetic Consortium for Colorectal Liver Metastasis.

Margonis GA, Amini N, Buettner S, Kim Y, Wang J, Andreatos N, Wagner D, Sasaki K, Beer A, Kamphues C, Morioka D, Løes IM, Imai K, He J, Pawlik TM, Kaczirek K, Poultsides G, Lønning PE, Burkhart R, Endo I, Baba H, Mischinger HJ, Aucejo FN, Kreis ME, Wolfgang CL, Weiss MJ.

Ann Surg. 2019 Aug 5. doi: 10.1097/SLA.0000000000003504. [Epub ahead of print]

PMID:
31389831
19.

Use of Machine Learning for Prediction of Patient Risk of Postoperative Complications After Liver, Pancreatic, and Colorectal Surgery.

Merath K, Hyer JM, Mehta R, Farooq A, Bagante F, Sahara K, Tsilimigras DI, Beal E, Paredes AZ, Wu L, Ejaz A, Pawlik TM.

J Gastrointest Surg. 2019 Aug 5. doi: 10.1007/s11605-019-04338-2. [Epub ahead of print]

PMID:
31385172
20.

Potential disease burden of patients with substance abuse undergoing major abdominal surgery: A propensity score-matched analysis.

Sahara K, Paredes AZ, Mehta R, Hyer JM, Tsilimigras DI, Merath K, Farooq SA, Wu L, Moro A, Beal EW, Endo I, Pawlik TM.

Surgery. 2019 Aug 1. pii: S0039-6060(19)30403-9. doi: 10.1016/j.surg.2019.06.018. [Epub ahead of print]

PMID:
31378476
21.

The Impact of Dedicated Cancer Centers on Outcomes Among Medicare Beneficiaries Undergoing Liver and Pancreatic Cancer Surgery.

Mehta R, Ejaz A, Hyer JM, Tsilimigras DI, White S, Merath K, Sahara K, Bagante F, Paredes AZ, Cloyd JM, Dillhoff M, Tsung A, Pawlik TM.

Ann Surg Oncol. 2019 Aug 2. doi: 10.1245/s10434-019-07677-1. [Epub ahead of print]

PMID:
31376033
22.

New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors: A Multi-institutional and National Data Analysis.

Zhang XF, Xue F, Dong DH, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Lv Y, Maithel SK, Pawlik TM.

Ann Surg. 2019 Jul 26. doi: 10.1097/SLA.0000000000003478. [Epub ahead of print]

PMID:
31356277
23.

Identifying the Optimal Lymph Node Number to Resect for Pancreatic Cancer: An Unsolved Problem.

Hyer JM, Tsilimigras DI, Pawlik TM.

J Am Coll Surg. 2019 Aug;229(2):222-223. doi: 10.1016/j.jamcollsurg.2019.03.004. No abstract available.

PMID:
31351568
24.

Short-Term Outcomes of Patients Undergoing Portal Vein Embolization: an ACS-NSQIP Procedure-Targeted Hepatectomy Analysis.

Bagante F, Spolverato G, Gleeson E, Merath K, Ejaz A, Cloyd J, Tsung A, Dillhoff M, Pitt HA, Pawlik TM.

J Gastrointest Surg. 2019 Jul 25. doi: 10.1007/s11605-019-04312-y. [Epub ahead of print]

PMID:
31346961
25.

Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection.

Bagante F, Spolverato G, Merath K, Weiss M, Alexandrescu S, Marques HP, Aldrighetti L, Maithel SK, Pulitano C, Bauer TW, Shen F, Poultsides GA, Soubrane O, Martel G, Koerkamp BG, Guglielmi A, Endo I, Pawlik TM.

Surgery. 2019 Jul 17. pii: S0039-6060(19)30344-7. doi: 10.1016/j.surg.2019.06.005. [Epub ahead of print]

PMID:
31326191
26.

Impact of Surgeon Volume on Outcomes and Expenditure Among Medicare Beneficiaries Undergoing Liver Resection: the Effect of Minimally Invasive Surgery.

Sahara K, Merath K, Hyer JM, Tsilimigras DI, Paredes AZ, Farooq A, Mehta R, Wu L, Beal EW, White S, Endo I, Pawlik TM.

J Gastrointest Surg. 2019 Jul 19. doi: 10.1007/s11605-019-04323-9. [Epub ahead of print]

PMID:
31325139
27.

Characterizing and Assessing the Impact of Surgery on Healthcare Spending Among Medicare Enrolled Preoperative Super-utilizers.

Hyer JM, Ejaz A, Diaz A, Tsilimigras DI, Gani F, White S, Pawlik TM.

Ann Surg. 2019 Sep;270(3):554-563. doi: 10.1097/SLA.0000000000003426.

PMID:
31305286
28.

Staging systems for gastric cancer: more complex than TNM.

Ejaz A, Pawlik TM.

Transl Gastroenterol Hepatol. 2019 Jun 11;4:44. doi: 10.21037/tgh.2019.05.11. eCollection 2019. No abstract available.

29.

Management and outcomes among patients with sarcomatoid hepatocellular carcinoma: A population-based analysis.

Wu L, Tsilimigras DI, Farooq A, Hyer JM, Merath K, Paredes AZ, Mehta R, Sahara K, Shen F, Pawlik TM.

Cancer. 2019 Jul 12. doi: 10.1002/cncr.32396. [Epub ahead of print]

PMID:
31299092
30.

In-hospital Mortality Following Pancreatoduodenectomy: a Comprehensive Analysis.

Merath K, Mehta R, Tsilimigras DI, Farooq A, Sahara K, Paredes AZ, Wu L, Ejaz A, Pawlik TM.

J Gastrointest Surg. 2019 Jul 10. doi: 10.1007/s11605-019-04307-9. [Epub ahead of print]

PMID:
31292889
31.

Hospice utilization among Medicare beneficiaries dying from pancreatic cancer.

Paredes AZ, Hyer JM, Tsilimigras DI, Mehta R, Sahara K, White S, Dillhoff ME, Ejaz A, Cloyd JM, Pawlik TM.

J Surg Oncol. 2019 Sep;120(4):624-631. doi: 10.1002/jso.25623. Epub 2019 Jul 9.

PMID:
31290170
32.

ASO Author Reflections: Which Patients Benefit the Most From Lymphadenectomy During Resection for Intrahepatic Cholangiocarcinoma?

Sahara K, Tsilimigras DI, Pawlik TM.

Ann Surg Oncol. 2019 Sep;26(9):2969-2970. doi: 10.1245/s10434-019-07608-0. Epub 2019 Jul 8. No abstract available.

PMID:
31286308
33.

Liver transplantation in patients with liver metastases from neuroendocrine tumors.

Spolverato G, Bagante F, Tsilimigras DI, Pawlik TM.

Minerva Chir. 2019 Jul 5. doi: 10.23736/S0026-4733.19.08119-7. [Epub ahead of print]

PMID:
31280548
34.

Data resource profile: State Inpatient Databases.

Metcalfe D, Zogg CK, Haut ER, Pawlik TM, Haider AH, Perry DC.

Int J Epidemiol. 2019 Jul 6. pii: dyz117. doi: 10.1093/ije/dyz117. [Epub ahead of print] No abstract available.

PMID:
31280297
35.

Impact of postoperative infective complications on long-term survival after liver resection for hepatocellular carcinoma.

Yang T, Liu K, Liu CF, Zhong Q, Zhang J, Yu JJ, Liang L, Li C, Wang MD, Li ZL, Wu H, Xing H, Han J, Lau WY, Zeng YY, Zhou YH, Gu WM, Wang H, Chen TH, Zhang YM, Zhang WG, Pawlik TM, Wu MC, Shen F.

Br J Surg. 2019 Aug;106(9):1228-1236. doi: 10.1002/bjs.11231. Epub 2019 Jul 5.

PMID:
31276196
36.

Features of synchronous versus metachronous metastasectomy in adrenal cortical carcinoma: Analysis from the US adrenocortical carcinoma database.

Prendergast KM, Smith PM, Tran TB, Postlewait LM, Maithel SK, Prescott JD, Pawlik TM, Wang TS, Glenn J, Hatzaras I, Shenoy R, Phay JE, Shirley LA, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Votanopoulos KI, Levine EA, Poultsides GA, Solórzano CC, Kiernan CM.

Surgery. 2019 Jul 1. pii: S0039-6060(19)30286-7. doi: 10.1016/j.surg.2019.05.024. [Epub ahead of print]

PMID:
31272813
37.

Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification.

Tsilimigras DI, Bagante F, Sahara K, Moris D, Hyer JM, Wu L, Ratti F, Marques HP, Soubrane O, Paredes AZ, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Workneh A, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM.

Ann Surg Oncol. 2019 Oct;26(11):3693-3700. doi: 10.1245/s10434-019-07580-9. Epub 2019 Jul 2.

PMID:
31267302
38.

Comment on: Major hepatectomy with or without pancreatoduodenectomy for advanced gallbladder cancer.

Tsilimigras DI, Moris D, Pawlik TM.

Br J Surg. 2019 Jul;106(8):1100-1101. doi: 10.1002/bjs.11238. No abstract available.

PMID:
31260585
39.

Outcomes of Patients with Scirrhous Hepatocellular Carcinoma: Insights from the National Cancer Database.

Farooq A, Merath K, Paredes AZ, Wu L, Tsilimigras DI, Hyer JM, Sahara K, Mehta R, Beal EW, Pawlik TM.

J Gastrointest Surg. 2019 Jun 26. doi: 10.1007/s11605-019-04282-1. [Epub ahead of print]

PMID:
31243715
40.

Effect of Surgical Margin Width on Patterns of Recurrence among Patients Undergoing R0 Hepatectomy for T1 Hepatocellular Carcinoma: An International Multi-Institutional Analysis.

Tsilimigras DI, Sahara K, Moris D, Hyer JM, Paredes AZ, Bagante F, Merath K, Farooq AS, Ratti F, Marques HP, Soubrane O, Azoulay D, Lam V, Poultsides GA, Popescu I, Alexandrescu S, Martel G, Guglielmi A, Hugh T, Aldrighetti L, Endo I, Pawlik TM.

J Gastrointest Surg. 2019 Jun 26. doi: 10.1007/s11605-019-04275-0. [Epub ahead of print]

PMID:
31243714
41.

Financial toxicity risk among adult patients undergoing cancer surgery in the United States: An analysis of the National Inpatient Sample.

Farooq A, Merath K, Hyer JM, Paredes AZ, Tsilimigras DI, Sahara K, Mehta R, Wu L, Cloyd JM, Ejaz A, Pawlik TM.

J Surg Oncol. 2019 Sep;120(3):397-406. doi: 10.1002/jso.25605. Epub 2019 Jun 24.

PMID:
31236957
42.

Resection of pancreatic neuroendocrine tumors: defining patterns and time course of recurrence.

Dong DH, Zhang XF, Lopez-Aguiar AG, Poultsides G, Makris E, Rocha F, Kanji Z, Weber S, Fisher A, Fields R, Krasnick BA, Idrees K, Smith PM, Cho C, Beems M, Dillhoff M, Maithel SK, Pawlik TM.

HPB (Oxford). 2019 Jun 21. pii: S1365-182X(19)30570-2. doi: 10.1016/j.hpb.2019.05.020. [Epub ahead of print]

PMID:
31235429
43.

Skilled nursing facility (SNF) utilization and impact of SNF star-quality ratings on outcomes following hepatectomy among Medicare beneficiaries.

Paredes AZ, Hyer JM, Tsilimigras DI, Merath K, Mehta R, Sahara K, Farooq SA, Wu L, White S, Pawlik TM.

HPB (Oxford). 2019 Jun 20. pii: S1365-182X(19)30562-3. doi: 10.1016/j.hpb.2019.05.012. [Epub ahead of print]

PMID:
31231061
44.

Endoscopic Ultrasound-Guided Confocal Laser Endomicroscopy Increases Accuracy of Differentiation of Pancreatic Cystic Lesions.

Krishna SG, Hart PA, Malli A, Kruger A, McCarthy ST, El-Dika S, Walker JP, Dillhoff ME, Manilchuk A, Schmidt CR, Pawlik TM, Porter K, Arnold CA, Cruz-Monserrate Z, Conwell DL.

Clin Gastroenterol Hepatol. 2019 Jun 17. pii: S1542-3565(19)30648-2. doi: 10.1016/j.cgh.2019.06.010. [Epub ahead of print]

PMID:
31220640
45.

Insurance Coverage Type Impacts Hospitalization Patterns Among Patients with Hepatopancreatic Malignancies.

Mehta R, Sahara K, Merath K, Hyer JM, Tsilimigras DI, Paredes AZ, Ejaz A, Cloyd JM, Dillhoff M, Tsung A, Pawlik TM.

J Gastrointest Surg. 2019 Jun 13. doi: 10.1007/s11605-019-04288-9. [Epub ahead of print]

PMID:
31197689
46.

Minimally Invasive Approach in the Setting of ALPPS Procedure: a Systematic Review of the Literature.

Melandro F, Giovanardi F, Hassan R, Larghi Laureiro Z, Ferri F, Rossi M, Mennini G, Pawlik TM, Lai Q.

J Gastrointest Surg. 2019 Sep;23(9):1917-1924. doi: 10.1007/s11605-018-04092-x. Epub 2019 Jun 13.

PMID:
31197682
47.

Disappearing liver metastases: A systematic review of the current evidence.

Tsilimigras DI, Ntanasis-Stathopoulos I, Paredes AZ, Moris D, Gavriatopoulou M, Cloyd JM, Pawlik TM.

Surg Oncol. 2019 Jun;29:7-13. doi: 10.1016/j.suronc.2019.02.005. Epub 2019 Feb 11. Review.

PMID:
31196496
48.

Survival Outcomes Among Patients With Gastric Adenocarcinoma Who Received Hyperthermic Intraperitoneal Chemotherapy With Cytoreductive Surgery.

Kimbrough CW, Beal E, Abdel-Misih S, Pawlik TM, Cloyd JM.

JAMA Surg. 2019 Jun 12. doi: 10.1001/jamasurg.2019.1698. [Epub ahead of print] No abstract available.

PMID:
31188418
49.

Travel to a high volume hospital to undergo resection of gallbladder cancer: does it impact quality of care and long-term outcomes?

Beal EW, Mehta R, Tsilimigras DI, Hyer JM, Paredes AZ, Merath K, Dillhoff ME, Cloyd JM, Ejaz A, Pawlik TM.

HPB (Oxford). 2019 Jun 8. pii: S1365-182X(19)30543-X. doi: 10.1016/j.hpb.2019.05.004. [Epub ahead of print]

PMID:
31186198
50.

Therapeutic Index Associated with Lymphadenectomy Among Patients with Intrahepatic Cholangiocarcinoma: Which Patients Benefit the Most from Nodal Evaluation?

Sahara K, Tsilimigras DI, Merath K, Bagante F, Guglielmi A, Aldrighetti L, Weiss M, Bauer TW, Alexandrescu S, Poultsides GA, Maithel SK, Marques HP, Martel G, Pulitano C, Shen F, Soubrane O, Koerkamp BG, Matsuyama R, Endo I, Pawlik TM.

Ann Surg Oncol. 2019 Sep;26(9):2959-2968. doi: 10.1245/s10434-019-07483-9. Epub 2019 May 31.

PMID:
31152272

Supplemental Content

Loading ...
Support Center